Epigral Ltd vs Narmada Gelatines Ltd Stock Comparison
Epigral Ltd vs Narmada Gelatines Ltd Stock Comparison
Last Updated on: Mar 23, 2026
Key Highlights
The Latest Trading Price of Epigral Ltd is ₹ 819.9 as of 23 Mar 15:30
. The P/E Ratio of Epigral Ltd changed from 16 on March 2022 to 22.9 on March 2025 . This represents a CAGR of 9.38% over 4 yearsThe P/E Ratio of Narmada Gelatines Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Epigral Ltd changed from ₹ 8191 crore on March 2025 to ₹ 4553 crore on March 2024 . This represents a CAGR of -11.08% over 5 yearsThe Market Cap of Narmada Gelatines Ltd changed from ₹ 192.68 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 years The revenue of Epigral Ltd for the Dec '25 is ₹ 602.68 crore as compare to the Sep '25 revenue of ₹ 589.1 crore. This represent the growth of 2.31% The revenue of Narmada Gelatines Ltd for the Dec '25 is ₹ 57.78 crore as compare to the Sep '25 revenue of ₹ 52.17 crore. This represent the growth of 10.75% The ebitda of Epigral Ltd for the Dec '25 is ₹ 108.26 crore as compare to the Sep '25 ebitda of ₹ 133.8 crore. This represent the decline of -19.09% The ebitda of Narmada Gelatines Ltd for the Dec '25 is ₹ 11.72 crore as compare to the Sep '25 ebitda of ₹ 10.31 crore. This represent the growth of 13.68% The net profit of Epigral Ltd changed from ₹ 103.63 crore to ₹ 39.11 crore over 7 quarters. This represents a CAGR of -42.70%
The net profit of Narmada Gelatines Ltd changed from ₹ 4.42 crore to ₹ 8.4 crore over 7 quarters. This represents a CAGR of 44.33%
The Dividend Payout of Epigral Ltd changed from 5.88 % on March 2023 to 7.26 % on March 2025 . This represents a CAGR of 7.28% over 3 yearsThe Dividend Payout of Narmada Gelatines Ltd changed from 71.51 % on March 2021 to 35.15 % on March 2025 . This represents a CAGR of -13.24% over 5 years .
About Epigral Ltd
Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products.
The Company was incorporated as a subsidiary of Meghmani Organics Limited.
Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of
Arrangement for Demerger and the said Scheme became effective from May 10, 2021.
The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21.
The Company is now among the leading players in India's chlor alkali industry.
In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.
About Narmada Gelatines Ltd
Narmada Gelatines Ltd., formerly known as Shaw Wallace Gelatines was incorporated on 13 Jan.'61 as Leiner-Knit Gelatin Company Pvt.
Ltd. In 1978, the Original Promoters, P Leiner & Sons fully divested in favour of Shah Wallace & Company.
In 1979, the name of the Company was changed to Shaw Wallace Gelatines Limited, and in the year 2002, the Company was renamed as Narmada Gelatines Limited.
The company manufactures Gelatine, Ossein, Di-Calcium Phosphate and Bone Meal.
It has manufacturing facility located at Jabalpur (M.P.).
Gelatine is basically a protein derivative of collagen, with a wide variety of end users.
FAQs for the comparison of Epigral Ltd and Narmada Gelatines Ltd
Which company has a larger market capitalization, Epigral Ltd or Narmada Gelatines Ltd?
Market cap of Epigral Ltd is 3,676 Cr while Market cap of Narmada Gelatines Ltd is 211 Cr
What are the key factors driving the stock performance of Epigral Ltd and Narmada Gelatines Ltd?
The stock performance of Epigral Ltd and Narmada Gelatines Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Epigral Ltd and Narmada Gelatines Ltd?
As of March 23, 2026, the Epigral Ltd stock price is INR ₹852.25. On the other hand, Narmada Gelatines Ltd stock price is INR ₹349.4.
How do dividend payouts of Epigral Ltd and Narmada Gelatines Ltd compare?
To compare the dividend payouts of Epigral Ltd and Narmada Gelatines Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.